Paper Poster Sessions
| titel | Date | Start | End |
|---|---|---|---|
| Vaccination: from bench to practice | 13/04/2019 | 15:30 | 16:30 |
| What's new in the pneumococcal vaccine world? | 13/04/2019 | 15:30 | 16:30 |
| Infection susceptibility | 13/04/2019 | 15:30 | 16:30 |
| Impact of immuno- suppression on diagnosis and treatment of infection | 13/04/2019 | 15:30 | 16:30 |
| Infection in solid organ transplantation | 13/04/2019 | 15:30 | 16:30 |
| Measles strikes back | 13/04/2019 | 15:30 | 16:30 |
| Reasons for getting vaccinated | 13/04/2019 | 15:30 | 16:30 |
| Early concepts for vaccine designs | 13/04/2019 | 15:30 | 16:30 |
| Biofilm susceptibility | 13/04/2019 | 15:30 | 16:30 |
| Implant infections | 13/04/2019 | 15:30 | 16:30 |
| More to learn about CDI: molecular diagnostics and epidemiology | 13/04/2019 | 15:30 | 16:30 |
| What else is new: emerging viruses | 13/04/2019 | 15:30 | 16:30 |
| Gut microbiome | 13/04/2019 | 15:30 | 16:30 |
| Microbiota in specific clinical presentations | 13/04/2019 | 15:30 | 16:30 |
| Flaviviruses around the world | 13/04/2019 | 15:30 | 16:30 |
| Experimental microbiome models and diagnostics | 13/04/2019 | 15:30 | 16:30 |
| Host-pathogen interactions | 13/04/2019 | 15:30 | 16:30 |
| Upper and lower respiratory tract microbiome | 13/04/2019 | 15:30 | 16:30 |
| Vaginal microbiome in health and disease | 13/04/2019 | 15:30 | 16:30 |
| On the forefront of respiratory viral diagnostic methods | 13/04/2019 | 15:30 | 16:30 |
| Biofilm eradication strategies | 13/04/2019 | 15:30 | 16:30 |
| Biofilm formation during infection | 13/04/2019 | 15:30 | 16:30 |
| Protozoan tissue infections: Leishmania and Toxoplasma | 13/04/2019 | 15:30 | 16:30 |
| Advances in the diagnosis of parasitic infections | 13/04/2019 | 15:30 | 16:30 |
| Epidemiology of parasitic infections | 13/04/2019 | 15:30 | 16:30 |
| Viruses in immuno- compromised hosts | 13/04/2019 | 15:30 | 16:30 |
| What`s new in respiratory viruses | 13/04/2019 | 15:30 | 16:30 |
| Enteric viruses: what's new | 13/04/2019 | 15:30 | 16:30 |
| All you need .... for lab automation! | 13/04/2019 | 15:30 | 16:30 |
| Applications of mass spectrometry | 13/04/2019 | 15:30 | 16:30 |
| Congenital CMV infection | 13/04/2019 | 15:30 | 16:30 |
| Clinical parasitology update | 13/04/2019 | 15:30 | 16:30 |
| Bone and joint infections | 13/04/2019 | 15:30 | 16:30 |
| Infections in migrants and travellers | 13/04/2019 | 15:30 | 16:30 |
| Hydatid disease and alveolar echinococcosis | 13/04/2019 | 15:30 | 16:30 |
| Malaria | 13/04/2019 | 15:30 | 16:30 |
| Other issues | 13/04/2019 | 15:30 | 16:30 |
| Insights from WGS: one world, one health | 13/04/2019 | 15:30 | 16:30 |
| Omics, Omics and even more Omics | 13/04/2019 | 15:30 | 16:30 |
| Clinical aspects of community-acquired pneumonia and respiratory tract infection | 13/04/2019 | 15:30 | 16:30 |
| Clinical pharmacokinetics, treatment strategies and prescribing of antifungals | 13/04/2019 | 15:30 | 16:30 |
| Biomarkers and antigen tests in fungal infection diagnostics | 13/04/2019 | 15:30 | 16:30 |
| Invasive aspergillosis: recent clinical experience and observations | 13/04/2019 | 15:30 | 16:30 |
| More to learn about CDI: clinical management | 13/04/2019 | 15:30 | 16:30 |
| CDI epidemiology and control | 13/04/2019 | 15:30 | 16:30 |
| News in non-tuberculous mycobacteria | 14/04/2019 | 12:30 | 12:30 |
| Presentation, treatment and outcomes of TB and MDR/XDR TB | 14/04/2019 | 12:30 | 12:30 |
| Helicobacter pylori | 14/04/2019 | 12:30 | 12:30 |
| Latent TB and TB epidemiology | 14/04/2019 | 12:30 | 12:30 |
| Diagnostic assays in tuberculosis | 14/04/2019 | 12:30 | 12:30 |
| Viral hepatits A to E: old friends, new problems | 14/04/2019 | 12:30 | 12:30 |
| HIV: clinical issues and epidemiology | 14/04/2019 | 12:30 | 12:30 |
| HIV treatment | 14/04/2019 | 12:30 | 12:30 |
| Viral infections of the central nervous system | 14/04/2019 | 12:30 | 12:30 |
| HIV: new advances in diagnostics | 14/04/2019 | 12:30 | 12:30 |
| Human papilloma virus: from disease to prevention | 14/04/2019 | 12:30 | 12:30 |
| New therapeutic approaches in viral infections | 14/04/2019 | 12:30 | 12:30 |
| New insights in the anaerobe world | 14/04/2019 | 12:30 | 12:30 |
| Infectious diarrhoea | 14/04/2019 | 12:30 | 12:30 |
| CNS infections | 14/04/2019 | 12:30 | 12:30 |
| Salmonella, Shigella and Campylobacter on the run | 14/04/2019 | 12:30 | 12:30 |
| Intraabdominal infections | 14/04/2019 | 12:30 | 12:30 |
| Infection due to Pseudomonas aeruginosa and other non-fermenters - many challenges | 14/04/2019 | 12:30 | 12:30 |
| Acinetobacter baumannii: formidable resistance threatening many parts of the world | 14/04/2019 | 12:30 | 12:30 |
| "High risk" clones of Escherichia coli and Klebsiella pneumoniae spreading around the world | 14/04/2019 | 12:30 | 12:30 |
| Enterobacterales: virulence and pathogenesis | 14/04/2019 | 12:30 | 12:30 |
| Infection in cystic fibrosis | 14/04/2019 | 13:30 | 14:30 |
| Polymyxin resistance in animals | 14/04/2019 | 13:30 | 14:30 |
| Surveillance of polymyxin resistance | 14/04/2019 | 13:30 | 14:30 |
| Carbapenemase detection: lateral flow test | 14/04/2019 | 13:30 | 14:30 |
| Molecular methods for carbapenemase detection | 14/04/2019 | 13:30 | 14:30 |
| Carbapenemase testing: culture-based methods | 14/04/2019 | 13:30 | 14:30 |
| Carbapenemases around the globe | 14/04/2019 | 13:30 | 14:30 |
| Polymyxins: mechanisms of resistance | 14/04/2019 | 13:30 | 14:30 |
| Chromosomal cephalosporinases: a "class" unto itself | 14/04/2019 | 13:30 | 14:30 |
| Respiratory viral epidemiology | 14/04/2019 | 13:30 | 14:30 |
| Global dissemination of NDM | 14/04/2019 | 13:30 | 14:30 |
| OXA-48 and other OXA enzymes are struggling! | 14/04/2019 | 13:30 | 14:30 |
| 16S rRNA methyltransferases | 14/04/2019 | 13:30 | 14:30 |
| Beta-lactamases here, there and everywhere (One Health) | 14/04/2019 | 13:30 | 14:30 |
| Global spread of MDR and XDR Klebsiella pneumoniae | 14/04/2019 | 13:30 | 14:30 |
| Cutting edge in fluoroquinolone resistance | 14/04/2019 | 13:30 | 14:30 |
| New beta-lactamase inhibitors: in vitro studies | 14/04/2019 | 13:30 | 14:30 |
| Tazobactam and sulbactam plus cephalosporins | 14/04/2019 | 13:30 | 14:30 |
| More studies on avibactam | 14/04/2019 | 13:30 | 14:30 |
| So many respiratory pathogens | 14/04/2019 | 13:30 | 14:30 |
| Diverse methodologies for MIC testing in Gram-negatives | 15/04/2019 | 12:30 | 13:30 |
| Colonisation with MDR Gram-negatives in the gut: epidemiology and consequences | 15/04/2019 | 12:30 | 13:30 |
| MIC testing various species | 15/04/2019 | 12:30 | 13:30 |
| Urinary pathogens: surveillance and trends | 15/04/2019 | 12:30 | 13:30 |
| One Health: the role of food and environment | 15/04/2019 | 12:30 | 13:30 |
| Molecular diagnostics in CNS infections | 15/04/2019 | 12:30 | 13:30 |
| Molecular detection of gastrointestinal pathogens | 15/04/2019 | 12:30 | 13:30 |
| Molecular diagnostics of respiratory tract infection pathogens | 15/04/2019 | 12:30 | 13:30 |
| Promiscuous plasmids on the attack: mobile genetic elements and their impact on antibiotic resistance | 15/04/2019 | 12:30 | 13:30 |
| Clinical epidemiology of infections due to MDR Gram-negatives | 15/04/2019 | 12:30 | 13:30 |
| Zoonoses: from animal to human | 15/04/2019 | 12:30 | 13:30 |
| Urinary tract infections | 15/04/2019 | 12:30 | 13:30 |
| Advances in the diagnosis of sexually transmitted infection | 15/04/2019 | 12:30 | 13:30 |
| Issues in sexual transmitted infections | 15/04/2019 | 12:30 | 13:30 |
| Sexually transmitted diseases complicated by antimicrobial resistance | 15/04/2019 | 12:30 | 13:30 |
| Recent experience with OPAT | 15/04/2019 | 13:30 | 14:30 |
| Results and impact of antimicrobial stewardship interventions | 15/04/2019 | 13:30 | 14:30 |
| Qualitative studies in stewardship and prescriber/patient surveys | 15/04/2019 | 13:30 | 14:30 |
| Computerised decision support and artificial intelligence to improve prescribing | 15/04/2019 | 13:30 | 14:30 |
| Knowing and rescuing old drugs for bad bugs | 15/04/2019 | 13:30 | 14:30 |
| Auditing antimicrobial use in hospitals and in the community | 15/04/2019 | 13:30 | 14:30 |
| TDM-guided dosing of antibacterials | 15/04/2019 | 13:30 | 14:30 |
| Recent research on the pharmacokinetics and safety of antibacterial agents | 15/04/2019 | 13:30 | 14:30 |
| Current issues in clinical pharmacokinetics | 15/04/2019 | 13:30 | 14:30 |
| Safety of antibacterial agents in the clinic | 15/04/2019 | 13:30 | 14:30 |
| Two sides of a coin: diagnostic and antimicrobial stewardship | 15/04/2019 | 13:30 | 14:30 |
| In vitro activity of investigational antibacterial agents | 15/04/2019 | 13:30 | 14:30 |
| Cefiderocol in vitro | 15/04/2019 | 13:30 | 14:30 |
| Preclinical evaluation of antibiotics in combination | 15/04/2019 | 13:30 | 14:30 |
| In vitro activity of newer antibacterial agents | 15/04/2019 | 13:30 | 14:30 |
| Evaluation of diverse antimicrobials in vitro and experimental models | 15/04/2019 | 13:30 | 14:30 |
| Preclinical PD assessment of antibacterial agents | 15/04/2019 | 13:30 | 14:30 |
| Mother nature to the rescue for MDR pathogens: phages, natural compounds and semi-synthetic derivatives | 15/04/2019 | 13:30 | 14:30 |
| New membrane-active antibiotics | 15/04/2019 | 13:30 | 14:30 |
| Screening for antimicrobial pharmacological properties | 15/04/2019 | 13:30 | 14:30 |
| Clinical efficacy studies for antimicrobial agents | 15/04/2019 | 13:30 | 14:30 |
| New topoisomerase inhibitors | 15/04/2019 | 13:30 | 14:30 |
| Pathogen spread and outbreaks | 16/04/2019 | 12:30 | 13:30 |
| MRSA detection | 16/04/2019 | 12:30 | 13:30 |
| Surveillance of healthcare-associated infections | 16/04/2019 | 12:30 | 13:30 |
| Hand hygiene and other infection control interventions | 16/04/2019 | 12:30 | 13:30 |
| Vascular catheter-associated infections | 16/04/2019 | 12:30 | 13:30 |
| Conventional approaches in fungal diagnostics | 16/04/2019 | 12:30 | 13:30 |
| Perspectives in infection control awareness and guidelines | 16/04/2019 | 12:30 | 13:30 |
| New approaches to fight fungi? | 16/04/2019 | 12:30 | 13:30 |
| Virulence and outcomes of fungal infections | 16/04/2019 | 12:30 | 13:30 |
| Molecular methods in fungal diagnostics | 16/04/2019 | 12:30 | 13:30 |
| Rapid phenotypic AST | 16/04/2019 | 12:30 | 13:30 |
| Disk diffusion sucseptibility testing | 16/04/2019 | 12:30 | 13:30 |
| Epidemiology of invasive Candida disease | 16/04/2019 | 12:30 | 13:30 |
| Combination susceptibility testing: 1+1 does not always equal 2 | 16/04/2019 | 12:30 | 13:30 |
| Detection of antibacterial resistance mechanisms | 16/04/2019 | 12:30 | 13:30 |
| Screening for and prevention of Staphylococcus aureus infections | 16/04/2019 | 12:30 | 13:30 |
| Preventing post-surgical infections | 16/04/2019 | 12:30 | 13:30 |
| Skin and soft tissue infections | 16/04/2019 | 12:30 | 13:30 |
| Environmental disinfection | 16/04/2019 | 12:30 | 13:30 |
| Gram-positives: only one world | 16/04/2019 | 12:30 | 13:30 |
| Resistance mechanisms in Gram-positive cocci | 16/04/2019 | 12:30 | 13:30 |
| Methicillin-resistant Staphylococcus: spanning the globe | 16/04/2019 | 12:30 | 13:30 |
| Topical antimicrobial agents and biocides | 16/04/2019 | 12:30 | 13:30 |
| Molecular & genomic surveillance of Gram-negatives | 16/04/2019 | 12:30 | 13:30 |
| Molecular & genomic surveillance of Gram-positive cocci | 16/04/2019 | 12:30 | 13:30 |
| Surveillance of resistance | 16/04/2019 | 12:30 | 13:30 |
| Modelling and predicting resistance: methods, drivers, consequences | 16/04/2019 | 12:30 | 13:30 |
| Endocarditis | 16/04/2019 | 12:30 | 13:30 |
| Gram-positive bacterial pathogenesis | 16/04/2019 | 12:30 | 13:30 |
| Focus Enterococcus: an expanding problem | 16/04/2019 | 12:30 | 13:30 |
| Advances in bloodstream infection diagnostics | 16/04/2019 | 12:30 | 13:30 |
| Staphylococcus bloodstream infection: a continuous challenge | 16/04/2019 | 12:30 | 13:30 |
| Current epidemiology of bloodstream infection and sepsis | 16/04/2019 | 12:30 | 13:30 |
| News on bloodstream infections in immuno- compromised patients | 16/04/2019 | 12:30 | 13:30 |
| Sepsis at the extemes of age | 16/04/2019 | 12:30 | 13:30 |
| Relevance of antimicrobial resistance and other factors for bloodstream infection outcomes | 16/04/2019 | 12:30 | 13:30 |
| Predicting sepsis and bloodstream infection severity and outcomes | 16/04/2019 | 12:30 | 13:30 |
| New findings in bone and joint infection pathogen diagnostics | 16/04/2019 | 12:30 | 13:30 |
| Antifungal susceptibility and resistance in yeast and moulds from around the world | 16/04/2019 | 12:30 | 13:30 |
| Mucomycosis and other uncommon fungi | 16/04/2019 | 12:30 | 13:30 |